Fertilization, fetal development, and delivery depend upon a coordinated series of events in the oocyte, the embryo, and the supporting tissues and fluids. Proteomic techniques which are capable of identifying and characterizing multiple proteins simultaneously have added new dimensions to the field of human reproduction. Application of these high throughput methodologies in pregnancy-related research has begun to provide a novel perspective on the biochemical pathways involved in pregnancy and its related disorders. Most of the existing research on human reproduction and gestation has focused on follicular fluid (FF) and amniotic fluid (AF). Proteome analysis of FF has yielded significant information relevant to oocyte maturation and quality. Studies performed on the protein content of AF cells and supernatant contributed to the comprehension of the underlying pathophysiology, clinical diagnosis of pregnancy-related disorders and identification of relevant disease biomarkers. Although proteome technologies in reproduction research are not as yet widely applied, characterization of the proteome of reproductive fluids can be expected to significantly improve maternal healthcare in the future.
No takes yet. Share an insight, caveat, or question.
Mavrou et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: